GlassScriptPhysician profile
Lynnae A Galella
NPI 1629471107
$5,099.12
in general payments reported to CMS, 2019-2025
43 companies · $1,686 in 2025
The $1,686 reported for 2025 was more than what 89% of Medical providers received nationally (typical 2025 total: $213).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $220 · 2022: $465 · 2023: $1,249 · 2024: $1,479 · 2025: $1,686.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,415.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,414.53 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pfizer INC. | $702.27 | 2021-2025 | |
| Novo Nordisk INC | $633.89 | 2021-2025 | Wegovy, Ozempic, Rybelsus |
| Glaxosmithkline, LLC. | $530.56 | 2023-2025 | Arexvy, Trelegy Ellipta, Shingrix |
| Lilly USA, LLC | $459.48 | 2022-2025 | Mounjaro, Jardiance, Zepbound |
| Amgen INC. | $412.87 | 2021-2025 | Repatha, Otezla, Prolia |
| Abbvie INC. | $321.40 | 2021-2025 | |
| E.R. Squibb & Sons, L.L.C. | $209.49 | 2022-2025 | Camzyos, Eliquis |
| Exact Sciences Corporation | $175.18 | 2023-2025 | Cologuard Collection Kit, The Cologuard Plus Collection Kit |
| Astrazeneca Pharmaceuticals LP | $124.99 | 2023-2025 | Farxiga, Breztri, Airsupra |
| Bayer Healthcare Pharmaceuticals INC. | $124.55 | 2022-2023 | |
| Medtronic, INC. | $120.00 | 2025 | Catalyft Pl Expandable Interbody System |
| Abbott Laboratories | $106.38 | 2023-2025 | Freestyle Libre 3 |
| Otsuka America Pharmaceutical, INC. | $99.62 | 2023-2025 | Rexulti |
| Axsome Therapeutics, INC. | $75.78 | 2025 | Auvelity |
| Phathom Pharmaceuticals, INC. | $73.96 | 2024-2025 | Voquezna |
Show all 43 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Lynnae Galella listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.